Reznick Yehuda 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Apr 18, 2024
Insider Transaction Report
Form 4
Reznick Yehuda
Director
Transactions
- Award
Common Stock
2024-04-17+29,800→ 29,800 total
Footnotes (1)
- [F1]Represents (i) a grant of 22,500 Restricted Stock Units ("RSUs") that will vest in equal installments on January 1, 2025, January 1, 2026 and January 1, 2027 and (ii) grants of 5,070 and 2,230 RSUs that will each vest in nearly equal installments on July 1, 2024, October 1, 2024 and January 1, 2025. In each case, the RSUs convert into the Issuer's Common Stock on a one-for-one basis.